| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce40bbce9138dae1d3765564fdca6772 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 |
| filingDate |
1985-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a66a671f5261108759397fbb4659bd53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871669ae3afd76fd45cd3e00e73d5b51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d76aa305413158ab7b320699bb1fe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b8af317abf371db9128445dfc3b0be |
| publicationDate |
1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1266613-A |
| titleOfInvention |
Inductive collagen based bone repair preparations |
| abstract |
INDUCTIVE COLLAGEN BASED BONE REPAIR PREPARATIONS Abstract A composition suitable for inductive bone implants is disclosed. The composition comprises a purified form of osteogenic factor in admixture with an carrier having a percentage of non-fibrillar collagen. The resulting implants are sufficiently hypoimmunogenic to be effective when implanted in xenogeneic hosts. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757330-B2 |
| priorityDate |
1984-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |